El Dr. Ignacio Duran nos ha acompañado desde el primer día en estos #20añosTACTICS , siendo testigo de nuestros primeros pasos.

Tras muchas formaciones médicas y eventos juntos, queremos agradecer al presidente de GO Norte su confianza y apoyo durante estos 20 años 🎂

¡Toma nota!

📣 Consulta ya el PROGRAMA del III Go Norte International GU Debates.

📆 24 y 25 de octubre
📍 Parador de Limpias

Coordina el Dr. Ignacio Duran, la Dra. nuria lainez y el Dr. Diego Cacho

#TumoresGenitourinarios GO Norte 
 
INSCRIPCIONES ➡️ gonorteoncologia.com/actividades/ii…

RENO is a retrospective #observationalstudy that describes the clinical characteristics, treatments, and health outcomes of patients with #metastasicrenalcellcarcinoma in Northern Spain.⁣

APICES CRO has collaborated in this study in data management and statistical analysis.

Over 610,000 people are diagnosed with #bladdercancer each year and we must raise our voices for every patient no matter where they live 🌏🌍🌎

We invite you to learn more about our #BladderCancerMonth24 campaign & get involved 👉 ow.ly/Gj9J50RmUYo #GetChecked

🌍 Did You Know? 🌍

#Bladdercancer ranks as the 9th most common cancer worldwide. Awareness is key in fighting this disease!

🔗 Discover more about global impact and support👉 worldbladdercancer.org/bladder-cancer/

#BladderCancerMonth24

Di adiós al tabaco #luchacontraeltabaco

¡Y recordad que la prevención sigue siendo el aspecto más importante para reducir los casos!

Avanzamos en la caracterización molecular del Ca. De Testículo

¡Nuestra primera publicación como grupo cooperativo! RENO Study: Clinical characteristics, treatment patterns and survival in RCC sciencedirect.com/science/articl…

Biomarker data from adjuvant ipi/nivo vs placebo study in renal cancer shows circulating Kidney injury marker-1(KIM-1), which is over expressed & prognostic in RCC #AACR24 , maybe important (along with PD-L1) in response to ipi/nivo. Patient selection for adjuvant IO is important

Subset data from belzutifan vs everolimus study in pretreated clear cell RCC #IKCS24 . We thought belzutifan would be better in good risk disease and with fewer lines of therapy but these data suggest that’s not the case. Biomakers will need to be biological rather than clinical

GoNorte representando a todos sus hospitales en el simposio Kidney Cancer con RENO STUDY #IKCSEU24

🚨🚨🚨🚨🚨

La AEMPS informa de problemas de suministro de CISPLATINO
🚨 📣
aemps.gob.es/informa/la-aem…

AEMPS SEOM

¿Demasiado ruido? Revisión de Dana-Farber sobre últimas novedades en GU

#EAU24 updated Adjuvan IO-based regimen in urothelial cancer!
European Association of Urology (EAU) OncoAlert Bladder Cancer Advocacy Network Fight Bladder Cancer ASCO ESMO - Eur. Oncology Uromigos UroToday.com Tom Powles Matt Galsky

Escucha el último podcast de @uromigos, realmente interesante!